Arca
Skip to content
Tools
Tools

Essential hypertension

Drug research and approvals for essential hypertension: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 42 studies of essential hypertension are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and the EU has 26 authorised medicines for it.

  • Recruiting worldwide: 42
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 26

Recruiting now

Newest posted first, of 42 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 1

Phase 3 12 of 27

Phase 2 12 of 16

Phase 1 or earlier 8

How its trials ended

491 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 103 whose ending is known, 80% met their primary endpoint, 2% missed it and 18% stopped early.

  • Completed, result not reported24149%
  • Met its primary endpoint8217%
  • Status unknown7515%
  • Ongoing7215%
  • Stopped: other or unclear133%
  • Stopped: enrollment or feasibility41%
  • Missed its primary endpoint2<1%
  • Stopped: sponsor or business decision1<1%
  • Stopped: funding1<1%

Medicines authorised in the EU

Newest first; 15 of 26
Mar 22, 2016Amlodipine / Valsartan MylanAmlodipine; valsartan · genericMylan Pharmaceuticals LimitedEMA ↗
Mar 13, 2013Actelsar HCTTelmisartan; hydrochlorothiazide · genericActavis Group PTC ehfEMA ↗
Dec 7, 2011EdarbiAzilsartan medoxomilTakeda Pharma A/SEMA ↗
Oct 3, 2011Telmisartan Teva PharmaTelmisartan · genericTeva B.V.EMA ↗
Mar 4, 2011IfirmacombiIrbesartan; hydrochlorothiazide · genericKRKA tovarna zdravil d.d. Novo mestoEMA ↗
Oct 7, 2010TwynstaTelmisartan; amlodipineBoehringer Ingelheim International GmbHEMA ↗
Sep 29, 2010Telmisartan ActavisTelmisartan · genericActavis Group PTC ehfEMA ↗
Jun 4, 2010ToluraTelmisartan · genericKRKA tovarna zdravil d.d. Novo mestoEMA ↗
Nov 26, 2009Irbesartan/Hydrochlorothiazide TevaIrbesartan; hydrochlorothiazide · genericTeva B.V.EMA ↗
Nov 3, 2009Dafiro HCTAmlodipine besilate; valsartan; hydrochlorothiazideNovartis Europharm LimitedEMA ↗
Nov 3, 2009Copalia HCTAmlodipine; valsartan; hydrochlorothiazideNovartis Europharm LimitedEMA ↗
Oct 30, 2009Irbesartan TevaIrbesartan · genericTeva B.V.EMA ↗
Oct 15, 2009Exforge HCTAmlodipine besilate; valsartan; hydrochlorothiazideNovartis Europharm LimitedEMA ↗
Dec 1, 2008Ifirmasta (previously Irbesartan Krka)Irbesartan · genericKRKA tovarna zdravil d.d. Novo mestoEMA ↗
Aug 22, 2007RasilezAliskirenLxo Ireland Designated Activity CompanyEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.